Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?

By Yahoo! Finance | Jun 20, 2024 at 03:35 AM EST

Scout Investments, Inc, under Carillon Tower Advisers, released the Q1 2024 investor letter for the "Carillon Scout Mid Cap Fund." The letter discusses market trends, highlights like BioMarin Pharmaceutical Inc., and emphasizes AI stocks for higher returns.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.